Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Sixteen Kenyans missing in Russia after army recruitment - 2Why Tourists May Want To Reconsider Traveling To This Popular Spot In Italy In 2026
- 3Mummified cheetahs found in Saudi caves shed light on lost populations
- 4Poll: By a 2-to-1 margin, Americans say Trump has done more to raise prices than lower them
- 5I’m a neuroscientist who taught rats to drive − their joy suggests how anticipating fun can enrich human life
- The best overlooked performances of 2025
- Vote In favor of Your Favored Comupter Game
- The Best Portable Applications for Psychological wellness and Prosperity
- Reports: Germany plans expansion of foreign intelligence powers
- IDF uncovers 7 km.-long Gaza terror tunnel where Hamas held Hadar Goldin
- 2026 Golden Globes live updates: Red carpet arrivals will kick off the night; Nikki Glaser set to host
- The most effective method to Offset Album Rates with Liquidity Needs
- Manual for Instructive Application for Youngsters
- Top German court to rule on claims by Wirecard shareholders
